Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 38Unknown 17Recruiting 16Not yet recruiting 12Active not recruiting 6Withdrawn 2Terminated 2Suspended 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 993Neoplasms 852Carcinoma, Non-Small-Cell Lung 845Prostatic Neoplasms 528Neoplasm Metastasis 501Leukemia, Myeloid, Acute 489Melanoma 456Colorectal Neoplasms 447Multiple Myeloma 441Lung Neoplasms 422Pancreatic Neoplasms 353Recurrence 350Lymphoma 350Ovarian Neoplasms 341Lymphoma, Non-Hodgkin 329Leukemia 324Leukemia, Lymphocytic, Chronic, B-Cell 302Precursor Cell Lymphoblastic Leukemia-Lymphoma 271Carcinoma, Renal Cell 256Head and Neck Neoplasms 246Brain Neoplasms 245Carcinoma, Hepatocellular 234Glioblastoma 232Squamous Cell Carcinoma of Head and Neck 231Myelodysplastic Syndromes 231Lymphoma, Large B-Cell, Diffuse 228Lymphoma, Follicular 219Colonic Neoplasms 191Stomach Neoplasms 182Rectal Neoplasms 175

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interventional × Breast Cancer Lymphedema × Clear all
NCT02994771 2023-04-24

A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema

Herantis Pharma Plc.

Phase 1 Terminated
15 enrolled
Breast

Breast Cancer Lymphedema

NCT04073823 2023-01-18

A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema Patients

Tactile Medical

Phase NA Terminated
2 enrolled 15 charts
Breast

Breast Cancer Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡